Download This PaperDecoding the Tecfidera Case: The Court of Justice of the European Union’s Verdict on the “Same Global Marketing Authorisation”
European Journal of Risk Regulation, volume 14, issue 4, 2023[10.1017/err.2023.51]
10 Pages Posted: 25 Feb 2025 Last revised: 25 Feb 2025
Date Written: July 01, 2023
Abstract
Headline: Determination of the “same global marketing authorisation” (area of discussion.)
Keywords: Determination, Same global marketing authorisation, European Commission Pharmaceutical Works Polpharma S.A., Medicinal products, Tecfidera
JEL Classification: K32
Suggested Citation: Suggested Citation
Parwani, Pramiti, Decoding the Tecfidera Case: The Court of Justice of the European Union’s Verdict on the “Same Global Marketing Authorisation” (July 01, 2023). European Journal of Risk Regulation, volume 14, issue 4, 2023[10.1017/err.2023.51], Amsterdam Law School Research Paper No. 2023-51, Law Centre for Health & Life Research Paper No. 2023-08, Available at SSRN: https://ssrn.com/abstract=5153591 or http://dx.doi.org/10.2139/ssrn.5153591
Do you have a job opening that you would like to promote on SSRN?
Feedback
Feedback to SSRN